JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALLES, G. A.
Right arrow Articles by PRINZMETAL, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ALLES, G. A.
Right arrow Articles by PRINZMETAL, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 48, Issue 2, 161-174, 1933
Copyright © 1933 by American Society for Pharmacology and Experimental Therapeutics


THE COMPARATIVE PHYSIOLOGICAL ACTIONS OF dl-beta-PHENYLISOPROPYLAMINES II. BRONCHIAL EFFECT

GORDON A. ALLES 1 and MYRON PRINZMETAL 1

1 From the Laboratories of George Piness, M.D., Los Angeles, the Pharmacological Laboratory and the Department of Surgery, Division of Thoracic Surgery, of the University of California Medical School, San Francisco

1. Previous work on the bronchial effects of beta-phenylethylamine and its hydroxyphenyl type of derivatives is reviewed.

2. beta-phenylethylamine and beta-phenylisopropylamine, intravenously injected into pithed dogs or cats, dilate bronchi that exhibit natural or induced tone. Larger doses of these compounds than of epinephrine are required for appreciable dilator effect but definite evaluation is difficult. The bronchodilator effect of beta-phenylisopropylamine is more prolonged than that of beta-phenylethylamine but is of comparable intensity.

3. beta-4-hydroxyphenylethylamine and beta-4-hydroxyphenylisopropylamine, intravenously injected into pithed dogs or cats, dilate bronchi that exhibit natural or induced tone. Larger doses of these compounds than of epinephrine are required for appreciable dilator effect but definite evaluation is difficult. The bronchodilator effect of beta-4-hydroxyphenylisopropylamine is more prolonged than that of beta-4-hydroxyphenylethylamine but is of comparable intensity.

4. beta-3,4-dihydroxyphenylethylamine and beta-3,4-dihydroxyphenylisopropylamine, intravenously injected into pithed dogs or cats, dilate bronchi that exhibit natural or induced tone. Both these compounds are about one-fiftieth as effective as epinephrine in their bronchial effects, but exhibit a longer duration of effect, that of beta-3,4-dihydroxyphenylisopropylamine being the most prolonged.

5. Study of bronchodilator effects in pithed guinea pigs showed that the method is not generally useful for epinephrine or the compounds of the present study.

6. Bronchial perfusion effects, through the trachea of isolated guinea pig lungs, were not evident with the phenyl or hydroxyphenyl derivatives in the doses used. The dihydroxyphenyl derivatives did exhibit bronchodilator effects but quantitative comparisons of their effect will require further work.

7. A discussion is given of the apparent relationship between the relative pressor and bronchial effects of the compounds used for the present work.

Submitted on September 21, 1932







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1933 by the American Society for Pharmacology and Experimental Therapeutics.